Piao, Y., Park, S. Y., Henry, V., Smith, B. D., Tiao, N., Flynn, D. L., & de Groot, J. F. (2016). Novel MET/TIE2/VEGFR2 inhibitor altiratinib inhibits tumor growth and invasiveness in bevacizumab-resistant glioblastoma mouse models. Neuro Oncol.
Citación estilo ChicagoPiao, Yuji, Soon Young Park, Verlene Henry, Bryan D. Smith, Ningyi Tiao, Daniel L. Flynn, and John F. de Groot. "Novel MET/TIE2/VEGFR2 Inhibitor Altiratinib Inhibits Tumor Growth and Invasiveness in Bevacizumab-resistant Glioblastoma Mouse Models." Neuro Oncol 2016.
Cita MLAPiao, Yuji, et al. "Novel MET/TIE2/VEGFR2 Inhibitor Altiratinib Inhibits Tumor Growth and Invasiveness in Bevacizumab-resistant Glioblastoma Mouse Models." Neuro Oncol 2016.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.